AEGLEA BIOTHERAPEUTICS INC (AGLE) Stock Balance Sheet
USA - NASDAQ:AGLE - US00773J2024 - Common Stock
12.01 USD
+0.97 (+8.79%)
11.88 USD
-0.13 (-1.08%)
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 90.60M | 34.90M | 15.10M | 90.10M | 19.30M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 113.00M | 20.80M | 78.00M | 56.20M | 52.70M | |||
| Receivables | 200.00K | 400.00K | 800.00K | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 2.20M | 6.20M | 4.90M | 3.50M | 2.60M | |||
| Total Current Assets | 205.90M | 62.30M | 98.90M | 149.80M | 74.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0 | 7.20M | 9.20M | 9.90M | 7.20M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 1.30M | 1.60M | 1.90M | 1.90M | 1.50M | |||
| Total Non-Current Assets | 1.40M | 8.80M | 11.00M | 11.80M | 8.70M | |||
| TOTAL ASSETS | 207.30M | 71.10M | 109.90M | 161.60M | 83.20M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | 0 | 400.00K | 0 | 0 | |||
| Accrued Expenses | 15.90M | 13.40M | 14.00M | 14.20M | 15.20M | |||
| Accounts Payable | 21.50M | 700.00K | 3.30M | 2.30M | 3.20M | |||
| Other Current Liabilities | 7.50M | 500.00K | 2.40M | null | null | |||
| Total Current Liabilities | 44.90M | 14.70M | 20.10M | 16.40M | 18.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 20.70M | 6.20M | 5.80M | 5.30M | 4.70M | |||
| Total Non-Current Liabilities | 20.70M | 6.10M | 5.90M | 5.40M | 4.70M | |||
| TOTAL LIABILITIES | 65.60M | 20.80M | 26.00M | 21.80M | 23.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -701.20M | -425.60M | -341.80M | -276.00M | -195.10M | |||
| Additional Paid In Capital | 456.00M | 476.00M | 425.80M | 415.80M | 255.10M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 387.10M | 0 | 0 | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -100.00K | 0 | 0 | 0 | 100.00K | |||
| Shares Outstanding | 4.00M | 2.60M | 2.00M | 1.90M | 1.20M | |||
| Tangible Book Value per Share | -61.35 | 19.3462 | 41.95 | 73.5789 | 50.0833 | |||
| Total Shareholders' Equity | 141.70M | 50.30M | 83.90M | 139.80M | 60.10M | |||
| TOTAL LIABILITIES AND EQUITY | 207.30M | 71.10M | 109.90M | 161.60M | 83.20M | |||
| Statistics | ||||||||
| Current Ratio | 4.59 | 4.24 | 4.92 | 9.13 | 4.05 | |||
| Return On Assets (ROA) | -142.03% | -117.89% | -59.87% | -50.06% | -94.05% | |||
| Return On Equity (ROE) | -207.78% | -166.64% | -78.43% | -57.86% | -130.20% | |||
All data in USD , ROIC based on taxRate of 0.21